Take our poll: How does Breast Cancer Awareness Month make you feel?
Donate to Breastcancer.org when you checkout at Walgreens in October. Learn more about our Walgreens collaboration.
Promising New Treatment for Metastatic Breast Cancer
moderators
Posts: 8,558
Promising New Treatment for Metastatic Breast Cancer
Nov 2, 2023
Dr. Aditya Bardia discusses encouraging results from a study on a new medicine for hormone receptor-positive, HER2-negative breast cancer.
At the European Society for Medical Oncology (ESMO) 2023 Congress Aditya Bardia, MD, MPH, presented results from the TROPION-Breast01 trial, which is comparing a new antibody-drug conjugate, datopotamab-deruxtecan (dato-DXd), to doctors’ choice of chemotherapy for inoperable or metastatic, hormone receptor-positive, HER2-negative breast cancer that had grown while being treated with hormonal therapy and also had been treated with chemotherapy.
Listen to the podcast to hear Dr. Bardia explain:
- what an antibody-drug conjugate is
- the design of the TROPION-Breast01 study and the first results
- dato-DXd side effects
- how dato-DXd might fit into the current treatment landscape for metastatic breast cancer
2
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.